Clinical Features and Pharmacological Treatment of Migraine Patients Referred to Headache Specialists in Canada

Show simple item record Jelinski, SE en Becker, WJ en Christie, SM en Giammarco, R en Mackie, GF en Gawel, MJ en Eloff, AG en Magnusson, Jane en 2012-05-23T20:34:13Z en 2006 en
dc.identifier.citation Cephalalgia 26(5):578-588 May 2006 en
dc.identifier.issn 0333-1024 en
dc.identifier.uri en
dc.description.abstract We set out to examine selected clinical characteristics of migraine patients referred to neurologists specializing in headache in Canada, and to document their pharmacological therapy both before and after consultation with the neurologist. Demographic, clinical and pharmacotherapy data were collected at the time of consultation for 606 patients referred to five headache clinics and who were given a migraine diagnosis by the neurologist. Data were analysed as part of the Canadian Headache Outpatient Registry and Database (CHORD) Project. The mean age of the migraine patients was 39.7 years; and 82.5% were female. The majority of patients suffered severe impact from their headaches. Prior to consultation, 48.7% were taking a triptan; after consultation, 97.2% were on a triptan. Before consultation, 30.9% were on a prophylactic drug; after consultation, 70.4% were. 20.8% of patients were medication overusers. Of these medication overusers, 42.4% were overusing an opiate, usually in combination with other analgesics; 21.6% were overusing a triptan. Medication changes made by the neurologists at consultation included a large increase in the use of both triptans and prophylactic medications. Medication overuse, particularly opiate overuse, remains a significant problem in patients with migraine in Canada. en
dc.publisher International Headache Society en
dc.relation.ispartofseries Cephalalgia en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from en
dc.rights.uri en
dc.title Clinical Features and Pharmacological Treatment of Migraine Patients Referred to Headache Specialists in Canada en
dc.type Journal Article en
dc.identifier.doi 10.1111/j.1468-2982.2005.01077.x en
pubs.issue 5 en
pubs.begin-page 578 en
pubs.volume 26 en
dc.rights.holder Copyright: International Headache Society en
dc.identifier.pmid 16674767 en
pubs.end-page 588 en
dc.rights.accessrights en
pubs.subtype Article en
pubs.elements-id 46216 en
pubs.record-created-at-source-date 2010-09-01 en
pubs.dimensions-id 16674767 en

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace